Haemodynamic heterogeneity and treatment with the calcium channel blocker nicardipine during phaeochromocytoma surgery

被引:16
|
作者
Colson, P
Ryckwaert, F
Ribstein, J
Mann, C
Dareau, S
机构
[1] Hop Arnaud de Villeneuve, Serv Anesthesie Reanimat B, F-34295 Montpellier, France
[2] Hop Arnaud de Villeneuve, Serv Med Interne G, F-34295 Montpellier, France
关键词
surgery; pheochromocytoma; blood pressure; calcium antagonist;
D O I
10.1111/j.1399-6576.1998.tb05387.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Favourable outcome of phaeochromocytoma surgery requires that paroxysmal hypertension and arrhythmia be controlled, and that hypotension be prevented. Is nicardipine, a calcium channel blocking drug, always adequate ? Methods: Nineteen consecutive patients underwent surgery for phaeochromocytoma. Management was standardised with regards to anaesthesia and antihypertensive treatment. Nicardipine was used as a vasodilator and was given in order to maintain systemic vascular resistance lower than 1600 dyn.s.cm(-5). Results: Hypertension did not occur at any time during surgery in 6/19 patients. Blood pressure rose acutely in 3/19 patients at the time of tracheal intubation or surgical approach to the tumour, and was controlled by increased depth of anaesthesia. Hypertensive episodes occurred in 11/19 patients during tumour manipulation. Nicardipine always succeeded in maintaining low systemic vascular resistance but its dosage varied widely between patients (0.5 to 70 mg), a fact that may be accounted for by the striking intersubject variability of haemodynamic behaviour during surgery. In 7/11 patients, despite nicardipine treatment, sustained increase in blood pressure persisted with increased cardiac index, but low systemic vascular resistance. Following tumour removal, transient serious hypotension (MAP <60 mmHg) occurred in 4 patients, and was corrected by fluid volume expansion. Perioperative incidence of hypertension or hypotension was not related to preoperative clinical status. Conclusion: Adequate management of patients operated upon for phaeochromocytoma requires invasive monitoring, since the mechanisms underlying hypertensive crises are heterogeneous with regards to systemic vascular resistance and not predictable from preoperative data. Nicardipine provides a good control of vasoconstriction during phaeochromocytoma surgery with limited risk of serious hypotension after tumour removal.
引用
收藏
页码:1114 / 1119
页数:6
相关论文
共 50 条
  • [1] NICARDIPINE, A NEW CALCIUM-CHANNEL BLOCKER IN THE TREATMENT OF CHRONIC STABLE ANGINA
    DEEDWANIA, PC
    THAO, TP
    ANDREW, HT
    HOLSCHER, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) : 190 - 190
  • [2] A comparative study between a calcium channel blocker (nicardipine) and a combined α-β-blocker (labetalol) for the control of emergence hypertension during craniotomy for tumor surgery
    Kross, RA
    Ferri, E
    Leung, D
    Pratila, M
    Broad, C
    Veronesi, M
    Melendez, JA
    ANESTHESIA AND ANALGESIA, 2000, 91 (04): : 904 - 909
  • [3] USE OF A CALCIUM-CHANNEL BLOCKER (NICARDIPINE HCL) IN THE TREATMENT OF CHILDHOOD MOYAMOYA DISEASE
    HOSAIN, SA
    HUGHES, JT
    FOREM, SL
    WISOFF, J
    FISH, I
    JOURNAL OF CHILD NEUROLOGY, 1994, 9 (04) : 378 - 380
  • [4] THE USE OF A NEW CALCIUM-CHANNEL BLOCKER, NICARDIPINE, IN THE TREATMENT OF ACUTE HYPERTENSION IN PREGNANCY
    WALKER, JJ
    BJORNSSON, S
    GREER, IA
    CHEYNE, H
    MCEWAN, H
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY, 1987, 6 (01): : 76 - 76
  • [5] Haemodynamic monitoring with a pulse-wae system during phaeochromocytoma uring phaeochromocytoma surgery
    Garcia-Orellana, M.
    Rivas, G.
    Farre, C.
    Trillo, L.
    REVISTA ESPANOLA DE ANESTESIOLOGIA Y REANIMACION, 2014, 61 (02): : 116 - 117
  • [6] NICARDIPINE, A NEW CALCIUM-CHANNEL BLOCKER - ROLE FOR VASCULAR SELECTIVITY
    FUKYAMA, O
    CLINICAL CARDIOLOGY, 1989, 12 (08) : A11 - A11
  • [8] NICARDIPINE, A NEW INTRAVENOUS CALCIUM-CHANNEL BLOCKER IN HYPERTENSIVE EMERGENCIES
    WALLIN, D
    FLETCHER, E
    RAM, V
    WEBER, M
    MACCARTHY, P
    CLIFTON, G
    BOLDRICK, R
    WEBER, E
    CHUNG, D
    TURLAPATY, P
    VIRAY, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 145 - 145
  • [9] A STUDY OF A NEW SLOW CHANNEL CALCIUM BLOCKER, NICARDIPINE IN ESSENTIAL-HYPERTENSION
    JONES, RI
    HORNUNG, RS
    SONECHA, TN
    RAFTERY, EB
    CLINICAL SCIENCE, 1983, 64 (02) : P18 - P18
  • [10] Increased mortality of kainic acid by pretreatment with nicardipine, a calcium channel blocker in rats
    Fujii, T
    Ohata, T
    PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 1997, 73 (02): : 25 - 29